Greenpharma invests in the enzymatic synthesis domain

Greenpharma and ICOA of the University of Orleans joins their expertise to create an innovative platform of white biotechnology for cosmetics within the company. This platform aims at the development of new methods of enzymatic bioprocess at the pilote scale by producing new compounds. A product catalogue is being set up and the platform is […]

READ MORE

Kinnov Therapeutics, a spin-off in pharmaceutical development dedicated to combat against addiction

Kinnov Therapeutics is dedicated to the R&D of innovative therapies against addiction. Supported by experienced scientists in the drug discovery and development, we have identified a disruptive strategy to treat addicted people. KT-110, our first-in-class patented lead composition, enters phase 2 clinical trial for alcohol addiction. KT-110 associates two off-patent drugs demonstrating a synergistic effect […]

READ MORE